Qube Research & Technologies (QRT)’s Solid Biosciences SLDB Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SLDB Stock Details SLDB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-37,277	Closed	-$149K	–	3845
2024 Q4	$149K	Sell	37,277 -37,242	-50%	-$205K	﹤0.01%	2906
2024 Q3	$519K	Sell	74,519 -174,068	-70%	-$1.41M	﹤0.01%	2255
2024 Q2	$1.41M	Buy	248,587 +117,939	+90%	+$1.06M	﹤0.01%	1761
2024 Q1	$1.74M	Buy	130,648 +130,647	+13,064,700%	+$1.22M	﹤0.01%	1839
2023 Q4	$6	Hold	1	–	–	﹤0.01%	4200
2023 Q3	$3	Buy	+1	New	+$4	﹤0.01%	3993
2022 Q4	–	Sell	-3,765	Closed	-$26K	–	2945
2022 Q3	$26K	Sell	3,765 -234	-6%	-$2.36K	﹤0.01%	2263
2022 Q2	$37K	Buy	+3,999	New	+$41.6K	﹤0.01%	2180
2021 Q3	–	Sell	-6,607	Closed	-$363K	–	2724
2021 Q2	$363K	Buy	6,607 +3,964	+150%	+$262K	﹤0.01%	1461
2021 Q1	$219K	Buy	+2,643	New	+$292K	﹤0.01%	1617

Other funds holding SLDB

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Qube Research & Technologies (QRT)'s SLDB Position: Q1 2025 in Review

Qube Research & Technologies (QRT) sold out of Solid Biosciences (SLDB) in Q1 2025, closing a stake of 37,277 shares — an estimated $149K sold.

Qube Research & Technologies (QRT) first reported a position in SLDB in Q1 2021 and held it in 10 quarters. The position peaked at $1.74M in Q1 2024. 124 funds tracked by Wall St. Rank hold SLDB as of Q1 2025.

Qube Research & Technologies (QRT) reported no remaining Solid Biosciences position as of Q1 2025 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 37,277 Solid Biosciences shares in Q1 2025, an estimated $149K.
Qube Research & Technologies (QRT) first reported a position in Solid Biosciences in Q1 2021 and held it in 10 quarters.
Qube Research & Technologies (QRT)'s Solid Biosciences position peaked at $1.74M in Q1 2024.
124 funds tracked by Wall St. Rank held Solid Biosciences as of Q1 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2025, filed 15 May 2025.